Cargando…

Insulin analogues use in pregnancy among women with pregestational diabetes mellitus and risk of congenital anomaly: a retrospective population-based cohort study

OBJECTIVES: To evaluate the risk of major congenital anomaly associated with first-trimester exposure to insulin analogues compared with human insulin in offspring of women with pregestational diabetes. DESIGN AND SETTING: A population-based cohort of women with pregestational diabetes (n=1661) who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hao, Wender-Ozegowska, Ewa, Garne, Ester, Morgan, Margery, Loane, Maria, Morris, Joan K, Bakker, Marian K, Gatt, Miriam, de Walle, Hermien, Jordan, Susan, Materna-Kiryluk, Anna, Nelen, Vera, Thys, Guy, Wiesel, Awi, Dolk, Helen, de Jong-van den Berg, Lolkje T W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855464/ https://www.ncbi.nlm.nih.gov/pubmed/29478010 http://dx.doi.org/10.1136/bmjopen-2016-014972

Ejemplares similares

EUROmediCAT signal detection: an evaluation of selected congenital anomaly‐medication associations
por: Given, Joanne E., et al.
Publicado: (2016)

Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies
por: Dolk, Helen, et al.
Publicado: (2016)

Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control Study
por: Bergman, Jorieke E. H., et al.
Publicado: (2017)

Toward the effective surveillance of hypospadias.
por: Dolk, Helen, et al.
Publicado: (2004)

The quality and the accuracy of codes for terminations of pregnancy for fetal anomalies recorded in hospital databases in three countries in northern Europe
por: Garne, Ester, et al.
Publicado: (2022)

Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study
por: Given, Joanne E, et al.
Publicado: (2018)

Corin—The Early Marker of Preeclampsia in Pregestational Diabetes Mellitus
por: Boroń, Daniel, et al.
Publicado: (2022)

Multilevel analyses of related public health indicators: The European Surveillance of Congenital Anomalies (EUROCAT) Public Health Indicators
por: Best, Kate E., et al.
Publicado: (2020)

Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study
por: Jentink, Janneke, et al.
Publicado: (2010)

Ethics and legal requirements for data linkage in 14 European countries for children with congenital anomalies
por: Claridge, Hugh, et al.
Publicado: (2023)

Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome
por: Boyd, PA, et al.
Publicado: (2008)

The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review
por: de Jong, Josta, et al.
Publicado: (2016)

Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry
por: de Jonge, Linda, et al.
Publicado: (2015)

Prevalence of microcephaly in Europe: population based study
por: Morris, Joan K, et al.
Publicado: (2016)

Anti-asthmatic prescriptions in children with and without congenital anomalies: a European data linkage study.
por: Divin, Natalie, et al.
Publicado: (2022)

The use of health care databases for surveillance of congenital anomalies: A EUROlinkCAT study
por: Loane, M, et al.
Publicado: (2023)

EUROlinkCAT protocol for a European population-based data linkage study investigating the survival, morbidity and education of children with congenital anomalies
por: Morris, Joan K, et al.
Publicado: (2021)

Periconception glycemic control and congenital anomalies in women with pregestational diabetes
por: Dude, Annie M, et al.
Publicado: (2021)

Estimating Global Burden of Disease due to congenital anomaly: an analysis of European data
por: Boyle, Breidge, et al.
Publicado: (2018)

Detection and investigation of temporal clusters of congenital anomaly in Europe: seven years of experience of the EUROCAT surveillance system
por: Dolk, Helen, et al.
Publicado: (2015)

Trends in congenital anomalies in Europe from 1980 to 2012
por: Morris, Joan K., et al.
Publicado: (2018)

Ten years after the Dutch public health campaign on folic acid: the continuing challenge
por: de Walle, Hermien E. K., et al.
Publicado: (2008)

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark
por: Jordan, Sue, et al.
Publicado: (2016)

Survival of children with rare structural congenital anomalies: a multi-registry cohort study
por: Coi, Alessio, et al.
Publicado: (2022)

Survival, hospitalisation and surgery in children born with Pierre Robin sequence: a European population-based cohort study
por: Santoro, Michele, et al.
Publicado: (2023)

A core outcome set for the treatment of pregnant women with pregestational diabetes: an international consensus study
por: Kgosidialwa, O, et al.
Publicado: (2021)

Temporal and geographical variations in survival of children born with congenital anomalies in Europe: A multi‐registry cohort study
por: Santoro, Michele, et al.
Publicado: (2022)

Causes of death in children with congenital anomalies up to age 10 in eight European countries
por: Rissmann, Anke, et al.
Publicado: (2023)

Accuracy of congenital anomaly coding in live birth children recorded in European health care databases, a EUROlinkCAT study
por: Bakker, Marian K., et al.
Publicado: (2023)

Prescriptions for insulin and insulin analogues in children with and without major congenital anomalies: a data linkage cohort study across six European regions
por: Given, Joanne, et al.
Publicado: (2023)

Prevalence of vascular disruption anomalies and association with young maternal age: A EUROCAT study to compare the United Kingdom with other European countries
por: Morris, Joan K., et al.
Publicado: (2022)

Pregestational Diabetes and Congenital Heart Defects
por: Maduro, Catarina, et al.
Publicado: (2022)

Improving Information on Maternal Medication Use by Linking Prescription Data to Congenital Anomaly Registers: A EUROmediCAT Study
por: de Jonge, Linda, et al.
Publicado: (2015)

COVID‐19 in pregnancy—what study designs can we use to assess the risk of congenital anomalies in relation to COVID‐19 disease, treatment and vaccination?
por: Dolk, Helen, et al.
Publicado: (2022)

Long term trends in prevalence of neural tube defects in Europe: population based study
por: Khoshnood, Babak, et al.
Publicado: (2015)

Hospital length of stay among children with and without congenital anomalies across 11 European regions—A population-based data linkage study
por: Urhoj, Stine Kjaer, et al.
Publicado: (2022)

Epidemiology of Multiple Congenital Anomalies Before and After Implementation of a Nationwide Prenatal Screening Program in Denmark
por: Toxværd, Marlene E., et al.
Publicado: (2021)

Creating a population-based cohort of children born with and without congenital anomalies using birth data matched to hospital discharge databases in 11 European regions: Assessment of linkage success and data quality
por: Loane, Maria, et al.
Publicado: (2023)

Joint Effect of Maternal Tobacco Smoking and Pregestational Diabetes on Preterm Births and Congenital Anomalies: A Population-Based Study in Northern Italy
por: Borsari, Lucia, et al.
Publicado: (2018)

Prenatal diagnosis and pregnancy outcome of major structural anomalies detectable in the first trimester: A population‐based cohort study in the Netherlands
por: Bardi, Francesca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6uqhai0pn7m5pn2m1j334sro88